Regeneron Pharmaceuticals
REGN
REGN
553 hedge funds and large institutions have $29.4B invested in Regeneron Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 182 increasing their positions, 219 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
17% less repeat investments, than reductions
Existing positions increased: 182 | Existing positions reduced: 219
23% less call options, than puts
Call options by funds: $630M | Put options by funds: $822M
Holders
553
Holding in Top 10
11
Calls
$630M
Puts
$822M
Top Buyers
| 1 | +$462M | |
| 2 | +$266M | |
| 3 | +$195M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$89M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$79M |
Top Sellers
| 1 | -$249M | |
| 2 | -$162M | |
| 3 | -$114M | |
| 4 |
Two Sigma Investments
New York
|
-$103M |
| 5 |
Renaissance Technologies
New York
|
-$73.6M |